Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Vilardell
Observed names:
D Vilardell,
D. Vilardell,
Vilardell, David
Institution:
Grifols (Spain)
Observed institutions:
Hospital Clínic de Barcelona,
Almirall (Spain),
Grifols (Spain),
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
OpenAlex ID:
A5002965014
Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique
2008
·
Esperança Sevene
, Alda Mariano
, et al.
·
Drug Safety
·
34
Pharmacokinetics, surrogate efficacy and safety evaluations of a new human plasma-derived fibrinogen concentrate (FIB Grifols) in adult patients with congenital afibrinogenemia
2021
·
Cecil Reuben Ross
, Sitalakshmi Subramanian
, et al.
·
Thrombosis Research
·
9
Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases
2022
·
Graciela Navarro-Mora
, Joan J. Alberti
, et al.
·
International Immunopharmacology
·
6
PDF
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care setting
2016
·
Radek Wojcik
, Julia Lowin
, et al.
·
Journal of Medical Economics
·
5
PDF
Efectos del calcio y la vitamina D con y sin lactulosa en la densidad mineral ósea de mujeres postmenopáusicas con osteopenia: Ensayo piloto controlado y aleatorizado
2013
·
J. Blanch
, N. Guañabens
, et al.
·
Revista de Osteoporosis y Metabolismo Mineral
·
3
PDF
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
2020
·
Martin Kankam
, Rhonda Griffin
, et al.
·
Advances in Therapy
·
2
PDF
Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden
2016
·
E Stockfleth
, D Vilardell
, et al.
·
Value in Health
·
2
PTU-187 Sample size calculation in confirmatory trials in irritable bowel syndrome with constipation: experience with linaclotide (constella®)
2015
·
M Falques
, C Díaz
, et al.
PTU-185 Treatment satisfaction after retreatment and long-term therapy with linaclotide (constella®)
2015
·
C Díaz
, M Falques
, et al.
PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials
2015
·
C Díaz
, M Falques
, et al.
PTU-188 Statistical approaches to missing data in trials of irritable bowel syndrome with constipation: experience with linaclotide (constella®)
2015
·
M Falques
, C Díaz
, et al.
Show more works
View as search
Works count:
12
Citation count:
61
H-index:
4
I10-index:
1
Year
Topic
Type